BlackRock’s Kiora Pharmaceuticals KPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $112 | Hold |
58
| – | – | ﹤0.01% | 5607 |
|
|
2025
Q4 | $114 | Hold |
58
| – | – | ﹤0.01% | 5472 |
|
|
2025
Q3 | $161 | Hold |
58
| – | – | ﹤0.01% | 5391 |
|
|
2025
Q2 | $167 | Hold |
58
| – | – | ﹤0.01% | 5404 |
|
|
2025
Q1 | $175 | Sell |
58
-1,548
| -96% | -$5.38K | ﹤0.01% | 5372 |
|
|
2024
Q4 | $5.3K | Hold |
1,606
| – | – | ﹤0.01% | 5218 |
|
|
2024
Q3 | $5.88K | Hold |
1,606
| – | – | ﹤0.01% | 5031 |
|
|
2024
Q2 | $6.75K | Sell |
1,606
-1
| -0.1% | -$5 | ﹤0.01% | 5101 |
|
|
2024
Q1 | $10.2K | Hold |
1,607
| – | – | ﹤0.01% | 5085 |
|
|
2023
Q4 | $7.55K | Hold |
1,607
| – | – | ﹤0.01% | 5166 |
|
|
2023
Q3 | $8.21K | Hold |
1,607
| – | – | ﹤0.01% | 5215 |
|
|
2023
Q2 | $9.3K | Hold |
1,607
| – | – | ﹤0.01% | 5263 |
|
|
2023
Q1 | $48.3K | Hold |
1,607
| – | – | ﹤0.01% | 5126 |
|
|
2022
Q4 | $49.6K | Hold |
1,607
| – | – | ﹤0.01% | 5238 |
|
|
2022
Q3 | $89K | Buy |
1,607
+1,549
| +2,671% | +$121K | ﹤0.01% | 5211 |
|
|
2022
Q2 | $10K | Hold |
58
| – | – | ﹤0.01% | 5627 |
|
|
2022
Q1 | $13K | Hold |
58
| – | – | ﹤0.01% | 5617 |
|
|
2021
Q4 | $32K | Hold |
58
| – | – | ﹤0.01% | 5480 |
|
|
2021
Q3 | $47K | Hold |
58
| – | – | ﹤0.01% | 5288 |
|
|
2021
Q2 | $76K | Sell |
58
-15
| -21% | -$23.3K | ﹤0.01% | 5118 |
|
|
2021
Q1 | $130K | Hold |
73
| – | – | ﹤0.01% | 4807 |
|
|
2020
Q4 | $129K | Hold |
73
| – | – | ﹤0.01% | 4539 |
|
|
2020
Q3 | $103K | Hold |
73
| – | – | ﹤0.01% | 4507 |
|
|
2020
Q2 | $126K | Hold |
73
| – | – | ﹤0.01% | 4454 |
|
|
2020
Q1 | $136K | Hold |
73
| – | – | ﹤0.01% | 4297 |
|
|
2019
Q4 | $262K | Buy |
+73
| New | +$142K | ﹤0.01% | 4283 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5026 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5048 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4989 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5010 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5041 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5046 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4973 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4866 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4898 |
|
|
2017
Q2 | – | Sell |
-2
| Closed | -$19.7K | – | 4957 |
|
|
2017
Q1 | $28K | Buy |
+2
| New | +$22.4K | ﹤0.01% | 4553 |
|
Other funds holding KPRX
ACM
VCM
XT
VFT
TSS
RC
BlackRock's KPRX Position: Q1 2026 in Review
BlackRock held its Kiora Pharmaceuticals (KPRX) position steady in Q1 2026 at 58 shares worth $112. The position accounts for ﹤0.01% of the portfolio, ranked #5607.
BlackRock first reported a position in KPRX in Q1 2017 and has held it in 27 quarters since. The position peaked at $262K in Q4 2019. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.
- BlackRock held 58 shares of Kiora Pharmaceuticals worth $112 as of Q1 2026.
- BlackRock left its Kiora Pharmaceuticals share count unchanged in Q1 2026.
- Kiora Pharmaceuticals made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5607 holding.
- BlackRock first reported a position in Kiora Pharmaceuticals in Q1 2017 and has held it in 27 quarters since.
- BlackRock's Kiora Pharmaceuticals position peaked at $262K in Q4 2019.
- 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.